David P. Schenkein

2016

In 2016, David P. Schenkein earned a total compensation of $3.5M as President and Chief Executive Officer at Agios Pharmaceuticals, a 65% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$340,800
Option Awards$2,582,051
Salary$568,000
Other$9,928
Total$3,500,779

Schenkein received $2.6M in option awards, accounting for 74% of the total pay in 2016.

Schenkein also received $340.8K in non-equity incentive plan, $568K in salary and $9.9K in other compensation.

Rankings

In 2016, David P. Schenkein's compensation ranked 2,636th out of 14,075 executives tracked by ExecPay. In other words, Schenkein earned more than 81.3% of executives.

ClassificationRankingPercentile
All
2,636
out of 14,075
81st
Division
Manufacturing
903
out of 5,488
84th
Major group
Chemicals And Allied Products
265
out of 1,900
86th
Industry group
Drugs
192
out of 1,543
88th
Industry
Pharmaceutical Preparations
145
out of 1,173
88th
Source: SEC filing on April 18, 2018.

Schenkein's colleagues

We found five more compensation records of executives who worked with David P. Schenkein at Agios Pharmaceuticals in 2016.

2016

Andrew Hirsch

Agios Pharmaceuticals

Chief Financial Officer

2016

Steve Hoerter

Agios Pharmaceuticals

Chief Commercial Officer

2016

Christopher Bowden

Agios Pharmaceuticals

Chief Medical Officer

2016

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2016

Glenn Goddard

Agios Pharmaceuticals

Former Sr. Vice President, Finance

News

In-depth

You may also like